Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase.

Milkiewicz, Karen L; Weinberg, Linda R; Albom, Mark S; Angeles, Thelma S; Cheng, Mangeng; Ghose, Arup K; Roemmele, Renee C; Theroff, Jay P; Underiner, Ted L; Zificsak, Craig A; Dorsey, Bruce D.
Bioorg Med Chem; 18(12): 4351-62, 2010 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-20483621
Dysregulation of the anaplastic lymphoma kinase (ALK) is implicated in a variety of cancers. A series of tetrahydropyrido[2,3-b]pyrazines was constructed as ring-constrained analogs of a known aminopyridine kinase scaffold. Chemistry was developed to rapidly elaborate the SAR, structural elements impacting ALK inhibitory activity were exploited, and kinase selective analogs were identified that inhibit ALK with IC(50) values approximately 10 nM (enzyme) and approximately 150 nM (cell).
Selo DaSilva